Sign In
Get Clay Free →

Jialiang Liang, Ph.D.

Healthcare analyst at AB Arya

Jialiang Liang, Ph.D.

Jialiang Liang, Ph.D. is a healthcare analyst at AB Arya and a Vice President at AllianceBernstein in New York.1 He has over 10 years of experience in the finance and research fields.

Professional Experience

  • Vice President, Healthcare L/S Analyst AllianceBernstein September 2023 - Present1

  • Vice President J.P. Morgan January 2023 - September 20231

  • Equity Research Associate J.P. Morgan September 2021 - January 20231

  • Associate Director UBS August 2020 - September 20211

  • Equity Research Associate Citizens JMP Securities, LLC September 2019 - July 20201

  • Postdoctoral Associate Massachusetts Institute of Technology March 2017 - August 20191

Education

  • Doctor of Philosophy (PhD), Biomedical Science Icahn School of Medicine at Mount Sinai 2010 - 20171

  • Master of Science (M.S.), Stem cell biology University of Chinese Academy of Sciences 2007 - 20101

  • Bachelor of Science (B.S.), Biology Xiamen University 2003 - 20071

Liang is proficient in Cantonese, Mandarin, and English.1 He holds several financial licenses including Series 63, 86, 87, and SIE.1

Jialiang Liang, Ph.D.
Jialiang Liang, Ph.D., photo 1
Jialiang Liang, Ph.D., photo 2
Get intro to Jialiang
Add to my network

Experience

Vice President at AllianceBernstein since September 2023
['Vice President at J.P. Morgan (January 2023 - September 2023)', 'Equity Research Associate at J.P. Morgan (September 2021 - January 2023)', 'Associate Director at UBS (August 2020 - September 2021)', 'Equity Research Associate at Citizens JMP Securities, LLC (September 2019 - July 2020)', 'Postdoctoral Associate at Massachusetts Institute of Technology (March 2017 - August 2019)']

Education

['Doctor of Philosophy (PhD) in Biomedical Science from Icahn School of Medicine at Mount Sinai (2010 - 2017)', 'Master of Science (M.S.) in Stem Cell Biology from University of Chinese Academy of Sciences (2007 - 2010)', 'Bachelor of Science (B.S.) in Biology from Xiamen University (2003 - 2007)']

Location

New York, New York, United States

People also Viewed

Brigitte de Lima, PhD CFA avatar image
Brigitte de Lima, PhD CFA
Senior Director, Corporate Development at AstraZeneca
Rahul Sarugaser avatar image
Rahul Sarugaser
Managing Director, Equity Research, Biotech & Medtech at Raymond James
Leonard Kish avatar image
Leonard Kish
Building the infrastructure of Web3 since before it was called Web3.

Tags

healthcareanalytical skillsbiotechequity researchimmunologybiomedical sciencestem cell biologycancer cell biology

Mutual Connections

See who you know in common with Jialiang
Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
Contact Us•About Clay•

People also Viewed

Brigitte de Lima, PhD CFA avatar image
Brigitte de Lima, PhD CFA
Senior Director, Corporate Development at AstraZeneca
Rahul Sarugaser avatar image
Rahul Sarugaser
Managing Director, Equity Research, Biotech & Medtech at Raymond James
Leonard Kish avatar image
Leonard Kish
Building the infrastructure of Web3 since before it was called Web3.

Tags

healthcareanalytical skillsbiotechequity researchimmunologybiomedical sciencestem cell biologycancer cell biology

Mutual Connections

See who you know in common with Jialiang

Jialiang Liang, Ph.D.

Healthcare analyst at AB Arya

Jialiang Liang, Ph.D.
Jialiang Liang, Ph.D., photo 1
Jialiang Liang, Ph.D., photo 2
Get intro to Jialiang
Add to my network

Experience

Vice President at AllianceBernstein since September 2023
['Vice President at J.P. Morgan (January 2023 - September 2023)', 'Equity Research Associate at J.P. Morgan (September 2021 - January 2023)', 'Associate Director at UBS (August 2020 - September 2021)', 'Equity Research Associate at Citizens JMP Securities, LLC (September 2019 - July 2020)', 'Postdoctoral Associate at Massachusetts Institute of Technology (March 2017 - August 2019)']

Education

['Doctor of Philosophy (PhD) in Biomedical Science from Icahn School of Medicine at Mount Sinai (2010 - 2017)', 'Master of Science (M.S.) in Stem Cell Biology from University of Chinese Academy of Sciences (2007 - 2010)', 'Bachelor of Science (B.S.) in Biology from Xiamen University (2003 - 2007)']

Location

New York, New York, United States

Jialiang Liang, Ph.D.

Jialiang Liang, Ph.D. is a healthcare analyst at AB Arya and a Vice President at AllianceBernstein in New York.1 He has over 10 years of experience in the finance and research fields.

Professional Experience

  • Vice President, Healthcare L/S Analyst AllianceBernstein September 2023 - Present1

  • Vice President J.P. Morgan January 2023 - September 20231

  • Equity Research Associate J.P. Morgan September 2021 - January 20231

  • Associate Director UBS August 2020 - September 20211

  • Equity Research Associate Citizens JMP Securities, LLC September 2019 - July 20201

  • Postdoctoral Associate Massachusetts Institute of Technology March 2017 - August 20191

Education

  • Doctor of Philosophy (PhD), Biomedical Science Icahn School of Medicine at Mount Sinai 2010 - 20171

  • Master of Science (M.S.), Stem cell biology University of Chinese Academy of Sciences 2007 - 20101

  • Bachelor of Science (B.S.), Biology Xiamen University 2003 - 20071

Liang is proficient in Cantonese, Mandarin, and English.1 He holds several financial licenses including Series 63, 86, 87, and SIE.1

People also Viewed

Brigitte de Lima, PhD CFA avatar image
Brigitte de Lima, PhD CFA
Senior Director, Corporate Development at AstraZeneca
Rahul Sarugaser avatar image
Rahul Sarugaser
Managing Director, Equity Research, Biotech & Medtech at Raymond James
Leonard Kish avatar image
Leonard Kish
Building the infrastructure of Web3 since before it was called Web3.

Tags

healthcareanalytical skillsbiotechequity researchimmunologybiomedical sciencestem cell biologycancer cell biology

Mutual Connections

See who you know in common with Jialiang
Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
Contact Us•About Clay•
Explore your network in depth
Unlock your full potential with Clay
Try for free →